GLUCOCORTICOIDS DOSE-DEPENDENTLY INCREASE PLASMA-LEVELS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN MAN

Citation
B. Jilma et al., GLUCOCORTICOIDS DOSE-DEPENDENTLY INCREASE PLASMA-LEVELS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN MAN, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 1037-1040
Citations number
21
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
83
Issue
3
Year of publication
1998
Pages
1037 - 1040
Database
ISI
SICI code
0021-972X(1998)83:3<1037:GDIPOG>2.0.ZU;2-K
Abstract
Glucocorticoids increase neutrophil counts by decreasing the marginati on of neutrophils and mobilizing neutrophils from the bone marrow pool . The mechanisms for these effects however are not fully elucidated, b ut it has been demonstrated that dexamethasone enhances release of col ony stimulating factor (G-CSF) in-vitro. We therefore hypothesized, th at dexamethasone may increase plasma levels of G-CSF. A double blind, randomized, placebo-controlled, three-way cross-over trial was conduct ed in nine healthy men. Every subject received four identical infusion s of saline, 0.04 mg/kg or 1.0 mg/kg dexamethasone during three observ ation periods of 48 hours each. The low dose of dexamethasone increase d G-CSF levels from a baseline of 15.5 ng/L (CI: 10.6-20.4) by 240% (C I: 115-366%) at 24 hours. The high dexamethasone dose increased G-CSF levels from a baseline of 12.3 ng/L (CI: 9.7-14.9) by 871% (CI: 592-11 49%) at 24 hours (p=0.008 for all comparisons). No further increase wa s observed at 48 hours but the effect was less pronounced (p<0.008 and p=0.08 for the high and the low dose of dexamethasone, respectively). Granulocyte-macrophage-CSF (GM-CSF) levels were below the assay's det ection limit of 0.36 ng/L in all subjects. In conclusion, dexamethason e dose dependently increases G-CSF levels in healthy men, an effect wh ich may account for some of its effects on neutrophils.